Article
A panel of emerging EMT genes identified in malignant mesothelioma
19 Jan 2022
Abstract excerpt
Malignant mesothelioma (MESO) is a highly aggressive cancer with poor prognosis. Epithelial-mesenchymal transition (EMT) is a critical process in malignancies involved in tumor angiogenesis, progression, invasion and metastasis, immunosuppressive microenvironment and therapy resistance. However, there is a lack of specific biomarkers to identify EMT in MESO. Biphasic MESO with dual phenotypes could be an optimal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
